Titan Biotech Ltd.
BSE: TITANBIO · Specialty Chemicals · sector
₹314.30BSE close 2026-10-26
Key numbers
Market cap₹779 cr
Price₹314.30
52w high / low₹1,460 / ₹202
P/E13.1xSector median 22.6x
P/B4.3xSector median 2.6x
Book value₹73.3
Dividend yield0.21%Sector median 0.60%
ROE20.2%Sector median 10.6%
ROCE23.6%Sector median 12.9%
OPM19.4%Sector median 12.1%
Debt / equity0.02xSector median 0.18x
EV/EBITDA18.4xSector median 15.1x
Interest cover47.6x
Current ratio3.28x
Sales growth 3y+12.7%Sector median +5.0%
Profit growth 3y+12.4%Sector median +0.9%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 107 companies in Specialty Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹2 cr vs borrowings ₹4 cr (FY26): borrowings are higher by ₹2 cr.
- Operating profit covered interest 47.6x in the last 12 months.
- Other income was 19% of net profit in the last 12 months.
- Dividend paid in 4 of the last 5 financial years.
- Price ₹314.30 on 2026-10-26: -78.5% from the 52-week high, +55.6% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹496.15 · low ₹241.80
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 35 | 46 | 54 | 57 | 49 | 59 |
| EBITDA | 5 | 9 | 9 | 11 | 10 | 12 |
| OPM % | 13.0% | 18.8% | 17.2% | 19.2% | 19.9% | 21.1% |
| Other income | 1 | 1 | 1 | 1 | 2 | 2 |
| Net profit | 4 | 7 | 8 | 9 | 7 | 11 |
| EPS (₹) | 4.90 | 8.30 | 9.40 | 10.32 | 1.63 | 2.63 |
| Revenue YoY | +38.8% | +27.2% | ||||
| Profit YoY | +66.2% | +58.3% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 124 | 144 | 164 | 156 | 206 | 219 |
| EBITDA | 31 | 30 | 34 | 25 | 39 | 42 |
| Net profit | 22 | 21 | 24 | 22 | 30 | 34 |
| EPS (₹) | 26.24 | 25.44 | 28.64 | 26.06 | 7.23 | 23.98 |
| Revenue growth | +16.6% | +13.9% | -4.6% | +31.8% | – | |
| Profit growth | -3.0% | +12.5% | -9.0% | +38.8% | – | |
| Dividend / share (₹) | – | 1.50 | 1.80 | 2.00 | 2.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +12.7% | – | – |
| Net profit | +12.4% | – | – |
| EPS | -34.3% | – | – |
| Share price | – | -33.3% (2y) | -65.6% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 153 | 182 |
| Borrowings | 2 | 4 |
| Cash & equivalents | 6 | 2 |
| Total assets | 175 | 214 |
| Fixed assets | 57 | 51 |
| Capital work in progress | 2 | 2 |
| Investments | 33 | 60 |
| Receivables | 19 | 23 |
| Inventory | 51 | 56 |
| Payables | 5 | 9 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 20 | 30 |
| Cash from investing | -10 | -34 |
| Cash from financing | -8 | 0 |
| Capex | 9 | 9 |
| Free cash flow | 11 | 21 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 14.0% | 16.5% |
| ROCE % | 16.2% | 21.1% |
| Debtor days | 44 | 40 |
| Inventory days | 255 | 212 |
| Payable days | 26 | 32 |
| Cash conversion cycle (days) | 273 | 220 |
| Working capital days | 143 | 105 |
Peers in Specialty Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| PIDILITIND | ₹1,50,431 cr | 56.8x | 13.9x | 25.7% | 33.4% | 24.5% | +7.4% | 1.01% |
| FLUOROCHEM | ₹46,168 cr | 75.4x | 5.9x | 8.1% | 10.0% | 25.6% | -4.2% | 0.07% |
| NAVINFLUOR | ₹39,306 cr | 49.7x | 9.9x | 23.9% | 22.2% | 33.7% | +16.8% | 0.18% |
| DEEPAKNTR | ₹19,676 cr | 25.1x | 3.4x | 14.0% | 15.3% | 15.4% | -0.4% | 0.52% |
| AETHER | ₹19,529 cr | 82.8x | 8.0x | 10.1% | 11.4% | 30.9% | +21.2% | – |
| ATUL | ₹15,762 cr | 19.8x | 2.5x | 11.9% | 16.9% | 17.9% | +7.9% | 0.47% |
| AARTIIND | ₹15,539 cr | 29.3x | 2.6x | 9.2% | 8.0% | 14.9% | +7.8% | 0.24% |
| FINEORG | ₹15,328 cr | 35.0x | 5.8x | 17.7% | 21.3% | 21.7% | -7.8% | 0.22% |
| BASF | ₹13,174 cr | 20.5x | 3.3x | 16.9% | 22.0% | 5.9% | +3.1% | 0.66% |
| TITANBIO | ₹779 cr | 13.1x | 4.3x | 20.2% | 23.6% | 19.4% | +12.7% | 0.21% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-09-22 | Dividend | Final Dividend Rs 0.5 |
| 2025-09-19 | Dividend | Final Dividend Rs 2.0 |
| 2024-09-23 | Dividend | Dividend Rs 2.0 |
| 2023-09-22 | Dividend | Final Dividend Rs 1.8 |
| 2022-09-22 | Dividend | Final Dividend Rs 1.5 |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Commodities |
| Industry | Specialty Chemicals |
| Sub-industry | Specialty Chemicals |
| Symbol | TITANBIO |
| BSE code | 524717 |
| ISIN | INE150C01029 |
| Face value | ₹2.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.